LIFE TECHNOLOGIES CORPORATION for LIFE TECHNOLOGIES CORPORATION
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Food Industry (safety, labeling, etc.) FOO
Regulation regarding Shiga Toxin-Producing Escherichia coli in Certain Raw Beef Products; Provisions regarding testing requirements.
| Lobbyist | Covered position, as disclosed |
|---|---|
| AMY MUHLBERG | N/A |
Law Enforcement/Crime/Criminal Justice LAW
H.R.988/S.517and revision not yet numbered: Katie Sepich Enhanced DNA Collection Act of 2011; All provisions of the bill.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JANET LYNCH LAMBERT | N/A |
Copyright/Patent/Trademark CPT
H.R. 1249: Leahy-Smith American Invents Act; Provisions regarding false markings, virtual marking first to file, post grant review and inequitable conduct.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JANET LYNCH LAMBERT | N/A |
Budget/Appropriations BUD
S. 1599: Departments of Labor, Health and Human Services and Education, and Related Agencies Appropriations Act, FY12; Provisions regarding National Institutes of Health funding. H.R. 2112: Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act, 2012; Provisions regarding FDA funding.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JANET LYNCH LAMBERT | N/A |
| AMY MUHLBERG | N/A |
Medical/Disease Research/Clinical Labs MED
BETTER Care Act (No Bill number to date); Provisions regarding lab developed tests. Draft guidance regarding Commercially Distributed In Vitro Diagnostic Products Labeled for Research Use Only or Investigational Use Only: Frequently Asked Questions; Provisions regarding FDA regulation of certain diagnostics.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JANET LYNCH LAMBERT | N/A |
| AMY MUHLBERG | N/A |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.